{"transactions":[{"id":1473843,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":89744,"kind":"person","name":"Dubovsky Filip","position":1,"cik":"0001977361","reported_name":"Dubovsky Filip","relationship":{"officer":true,"officer_title":"President, R&D"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-20T21:08:39.000Z","date":"2024-06-17","kind":"exercise","planned":false,"acquired":false,"shares":12500,"price":6.09,"value":76125.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on the first anniversary of the grant date, and the remaining seventy-five percent (75%) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date."}],"balance_after":37500,"derivative":{"exercise_price":6.09,"expiration_date":"2033-03-27","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001593968-24-000879","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824000879/primary_01.xml","form_type":"4"}},{"id":1473842,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":89744,"kind":"person","name":"Dubovsky Filip","position":1,"cik":"0001977361","reported_name":"Dubovsky Filip","relationship":{"officer":true,"officer_title":"President, R&D"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-20T21:08:39.000Z","date":"2024-06-17","kind":"exercise","planned":false,"acquired":false,"shares":1404,"price":6.97,"value":9785.88,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on the first anniversary of the grant date, and the remaining seventy-five percent (75%) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date."}],"balance_after":46324,"derivative":{"exercise_price":6.97,"expiration_date":"2033-03-07","underlying":"Common Stock","underlying_shares":1404},"source":{"system":"sec-edgar","filing":"0001593968-24-000879","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824000879/primary_01.xml","form_type":"4"}},{"id":1473841,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":89744,"kind":"person","name":"Dubovsky Filip","position":1,"cik":"0001977361","reported_name":"Dubovsky Filip","relationship":{"officer":true,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2024-06-20T21:08:39.000Z","date":"2024-06-17","kind":"sale","planned":false,"acquired":false,"shares":1404,"price":14.54,"value":20414.16,"ownership":{"direct":true},"balance_after":66613,"source":{"system":"sec-edgar","filing":"0001593968-24-000879","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824000879/primary_01.xml","form_type":"4"}},{"id":1473840,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":89744,"kind":"person","name":"Dubovsky Filip","position":1,"cik":"0001977361","reported_name":"Dubovsky Filip","relationship":{"officer":true,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2024-06-20T21:08:39.000Z","date":"2024-06-17","kind":"sale","planned":false,"acquired":false,"shares":12500,"price":14.46,"value":180750.0,"ownership":{"direct":true},"balance_after":68017,"source":{"system":"sec-edgar","filing":"0001593968-24-000879","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824000879/primary_01.xml","form_type":"4"}},{"id":1473839,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":89744,"kind":"person","name":"Dubovsky Filip","position":1,"cik":"0001977361","reported_name":"Dubovsky Filip","relationship":{"officer":true,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2024-06-20T21:08:39.000Z","date":"2024-06-17","kind":"exercise","planned":false,"acquired":true,"shares":12500,"price":6.09,"value":76125.0,"ownership":{"direct":true},"balance_after":80517,"source":{"system":"sec-edgar","filing":"0001593968-24-000879","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824000879/primary_01.xml","form_type":"4"}},{"id":1473838,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":89744,"kind":"person","name":"Dubovsky Filip","position":1,"cik":"0001977361","reported_name":"Dubovsky Filip","relationship":{"officer":true,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2024-06-20T21:08:39.000Z","date":"2024-06-17","kind":"exercise","planned":false,"acquired":true,"shares":1404,"price":6.97,"value":9785.88,"ownership":{"direct":true},"balance_after":68017,"source":{"system":"sec-edgar","filing":"0001593968-24-000879","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824000879/primary_01.xml","form_type":"4"}},{"id":1516476,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":89744,"kind":"person","name":"Dubovsky Filip","position":1,"cik":"0001977361","reported_name":"Dubovsky Filip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-16T01:15:54.000Z","date":"2024-05-14","kind":"exercise","planned":false,"acquired":false,"shares":19652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the March 7, 2023 grant date, and the remaining seventy-five percent (75%) of the shares vested or will vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date."}],"balance_after":47728,"derivative":{"exercise_price":6.97,"expiration_date":"2033-03-07","underlying":"Common Stock","underlying_shares":19652},"source":{"system":"sec-edgar","filing":"0001104659-24-062148","document":"tm2414680-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924062148/tm2414680-1_4seq1.xml","form_type":"4"}},{"id":1516475,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":89744,"kind":"person","name":"Dubovsky Filip","position":1,"cik":"0001977361","reported_name":"Dubovsky Filip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2024-05-16T01:15:54.000Z","date":"2024-05-14","kind":"sale","planned":false,"acquired":false,"shares":47312,"price":13.9,"value":657636.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $13.86 to $14.00, inclusive. The Reporting Person undertakes to provide to Novavax, Inc. (the \"Company\"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":38953,"source":{"system":"sec-edgar","filing":"0001104659-24-062148","document":"tm2414680-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924062148/tm2414680-1_4seq1.xml","form_type":"4"}},{"id":1516474,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":89744,"kind":"person","name":"Dubovsky Filip","position":1,"cik":"0001977361","reported_name":"Dubovsky Filip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2024-05-16T01:15:54.000Z","date":"2024-05-14","kind":"exercise","planned":false,"acquired":true,"shares":19652,"price":6.97,"value":136974.44,"ownership":{"direct":true},"balance_after":86265,"source":{"system":"sec-edgar","filing":"0001104659-24-062148","document":"tm2414680-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924062148/tm2414680-1_4seq1.xml","form_type":"4"}},{"id":1561109,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":89744,"kind":"person","name":"Dubovsky Filip","position":1,"cik":"0001977361","reported_name":"Dubovsky Filip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Restricted Stock Units","published_at":"2024-03-26T23:00:53.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":144000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the March 1, 2024 grant date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the March 1, 2024 grant date, in each case subject to continued employment through such vesting date."}],"balance_after":144000,"derivative":{"underlying":"Common Stock","underlying_shares":144000},"source":{"system":"sec-edgar","filing":"0001104659-24-039163","document":"tm249879-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924039163/tm249879-2_4seq1.xml","form_type":"4"}},{"id":1582181,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":89744,"kind":"person","name":"Dubovsky Filip","position":1,"cik":"0001977361","reported_name":"Dubovsky Filip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Restricted Stock Units","published_at":"2024-03-13T00:46:00.000Z","date":"2024-03-10","kind":"exercise","planned":false,"acquired":false,"shares":5376,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the March 10, 2022 grant date, in each case subject to continued employment through such vesting date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the March 10, 2022 grant date, in each case subject to continued employment through such vesting date"}],"balance_after":5376,"derivative":{"underlying":"Common Stock","underlying_shares":5376},"source":{"system":"sec-edgar","filing":"0001104659-24-033620","document":"tm248710-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924033620/tm248710-2_4seq1.xml","form_type":"4"}},{"id":1582180,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":89744,"kind":"person","name":"Dubovsky Filip","position":1,"cik":"0001977361","reported_name":"Dubovsky Filip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2024-03-13T00:46:00.000Z","date":"2024-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":2597,"price":5.45,"value":14153.65,"ownership":{"direct":true},"balance_after":66613,"source":{"system":"sec-edgar","filing":"0001104659-24-033620","document":"tm248710-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924033620/tm248710-2_4seq1.xml","form_type":"4"}},{"id":1582179,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":89744,"kind":"person","name":"Dubovsky Filip","position":1,"cik":"0001977361","reported_name":"Dubovsky Filip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2024-03-13T00:46:00.000Z","date":"2024-03-10","kind":"exercise","planned":false,"acquired":true,"shares":5376,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":69210,"source":{"system":"sec-edgar","filing":"0001104659-24-033620","document":"tm248710-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924033620/tm248710-2_4seq1.xml","form_type":"4"}},{"id":1585003,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":89744,"kind":"person","name":"Dubovsky Filip","position":1,"cik":"0001977361","reported_name":"Dubovsky Filip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Restricted Stock Units","published_at":"2024-03-12T01:40:50.000Z","date":"2024-03-07","kind":"exercise","planned":false,"acquired":false,"shares":19444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3)\nanniversaries of the March 7, 2023 grant date, in each case subject to continued employment through such vesting date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3)\nanniversaries of the March 7, 2023 grant date, in each case subject to continued employment through such vesting date"}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":38886},"source":{"system":"sec-edgar","filing":"0001104659-24-033165","document":"tm248549-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924033165/tm248549-3_4seq1.xml","form_type":"4"}},{"id":1585002,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":89744,"kind":"person","name":"Dubovsky Filip","position":1,"cik":"0001977361","reported_name":"Dubovsky Filip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2024-03-12T01:40:50.000Z","date":"2024-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":9392,"price":5.61,"value":52689.12,"ownership":{"direct":true},"balance_after":63834,"source":{"system":"sec-edgar","filing":"0001104659-24-033165","document":"tm248549-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924033165/tm248549-3_4seq1.xml","form_type":"4"}},{"id":1585001,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":89744,"kind":"person","name":"Dubovsky Filip","position":1,"cik":"0001977361","reported_name":"Dubovsky Filip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2024-03-12T01:40:50.000Z","date":"2024-03-07","kind":"exercise","planned":false,"acquired":true,"shares":19444,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":73226,"source":{"system":"sec-edgar","filing":"0001104659-24-033165","document":"tm248549-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924033165/tm248549-3_4seq1.xml","form_type":"4"}},{"id":1708016,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":89744,"kind":"person","name":"Dubovsky Filip","position":1,"cik":"0001977361","reported_name":"Dubovsky Filip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Restricted Stock Units","published_at":"2023-12-18T22:00:29.000Z","date":"2023-12-14","kind":"exercise","planned":false,"acquired":false,"shares":2833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs subject to this grant under the Plan vested with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the December 14, 2020 grant date, in each case subject to continued employment with the Company through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs subject to this grant under the Plan vested with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the December 14, 2020 grant date, in each case subject to continued employment with the Company through such vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2833},"source":{"system":"sec-edgar","filing":"0001209191-23-058982","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123058982/doc4.xml","form_type":"4"}},{"id":1708015,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":89744,"kind":"person","name":"Dubovsky Filip","position":1,"cik":"0001977361","reported_name":"Dubovsky Filip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2023-12-18T22:00:29.000Z","date":"2023-12-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":1368,"price":5.69,"value":7783.92,"ownership":{"direct":true},"balance_after":53782,"source":{"system":"sec-edgar","filing":"0001209191-23-058982","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123058982/doc4.xml","form_type":"4"}},{"id":1708014,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":89744,"kind":"person","name":"Dubovsky Filip","position":1,"cik":"0001977361","reported_name":"Dubovsky Filip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2023-12-18T22:00:29.000Z","date":"2023-12-14","kind":"exercise","planned":false,"acquired":true,"shares":2833,"price":5.69,"value":16119.77,"ownership":{"direct":true},"balance_after":55150,"source":{"system":"sec-edgar","filing":"0001209191-23-058982","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123058982/doc4.xml","form_type":"4"}},{"id":1747923,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":89744,"kind":"person","name":"Dubovsky Filip","position":1,"cik":"0001977361","reported_name":"Dubovsky Filip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Restricted Stock Units","published_at":"2023-11-07T22:30:08.000Z","date":"2023-11-05","kind":"exercise","planned":false,"acquired":false,"shares":1400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs subject to this grant under the Plan vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the November 5, 2020 grant date, in each case subject to continued employment with the Company through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs subject to this grant under the Plan vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the November 5, 2020 grant date, in each case subject to continued employment with the Company through such vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1400},"source":{"system":"sec-edgar","filing":"0001209191-23-054625","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123054625/doc4.xml","form_type":"4"}},{"id":1747922,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":89744,"kind":"person","name":"Dubovsky Filip","position":1,"cik":"0001977361","reported_name":"Dubovsky Filip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2023-11-07T22:30:08.000Z","date":"2023-11-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":677,"price":7.06,"value":4779.62,"ownership":{"direct":true},"balance_after":52317,"source":{"system":"sec-edgar","filing":"0001209191-23-054625","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123054625/doc4.xml","form_type":"4"}},{"id":1747921,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":89744,"kind":"person","name":"Dubovsky Filip","position":1,"cik":"0001977361","reported_name":"Dubovsky Filip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2023-11-07T22:30:08.000Z","date":"2023-11-05","kind":"exercise","planned":false,"acquired":true,"shares":1400,"price":7.06,"value":9884.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were received by the reporting person in connection with vesting of restricted stock units (\"RSUs\")."}],"balance_after":52994,"source":{"system":"sec-edgar","filing":"0001209191-23-054625","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123054625/doc4.xml","form_type":"4"}},{"id":1778035,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":89744,"kind":"person","name":"Dubovsky Filip","position":1,"cik":"0001977361","reported_name":"Dubovsky Filip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Restricted Stock Units","published_at":"2023-09-19T21:16:01.000Z","date":"2023-09-16","kind":"exercise","planned":false,"acquired":false,"shares":12644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-half (1/2) of the RSUs on each of the first two (2) anniversaries of the September 16, 2021 grant date, in each case subject to continued employment with the Company through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-half (1/2) of the RSUs on each of the first two (2) anniversaries of the September 16, 2021 grant date, in each case subject to continued employment with the Company through such vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":12644},"source":{"system":"sec-edgar","filing":"0001209191-23-050009","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123050009/doc4.xml","form_type":"4"}},{"id":1778034,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":89744,"kind":"person","name":"Dubovsky Filip","position":1,"cik":"0001977361","reported_name":"Dubovsky Filip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2023-09-19T21:16:01.000Z","date":"2023-09-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":6108,"price":7.71,"value":47092.68,"ownership":{"direct":true},"balance_after":51594,"source":{"system":"sec-edgar","filing":"0001209191-23-050009","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123050009/doc4.xml","form_type":"4"}},{"id":1778033,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":89744,"kind":"person","name":"Dubovsky Filip","position":1,"cik":"0001977361","reported_name":"Dubovsky Filip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2023-09-19T21:16:01.000Z","date":"2023-09-16","kind":"exercise","planned":false,"acquired":true,"shares":12644,"price":7.71,"value":97485.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were received by the reporting person in connection with vesting of restricted stock units (\"RSUs\")."}],"balance_after":57702,"source":{"system":"sec-edgar","filing":"0001209191-23-050009","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123050009/doc4.xml","form_type":"4"}},{"id":1848184,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":89744,"kind":"person","name":"Dubovsky Filip","position":1,"cik":"0001977361","reported_name":"Dubovsky Filip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Restricted Stock Units","published_at":"2023-06-21T20:40:33.000Z","date":"2023-06-16","kind":"exercise","planned":false,"acquired":false,"shares":4155,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the June 16, 2020 grant date, in each case subject to continued employment with the Company through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the June 16, 2020 grant date, in each case subject to continued employment with the Company through such vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4155},"source":{"system":"sec-edgar","filing":"0001209191-23-038804","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123038804/doc4.xml","form_type":"4"}},{"id":1848183,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":89744,"kind":"person","name":"Dubovsky Filip","position":1,"cik":"0001977361","reported_name":"Dubovsky Filip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2023-06-21T20:40:33.000Z","date":"2023-06-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":2007,"price":8.04,"value":16136.28,"ownership":{"direct":true},"balance_after":45058,"source":{"system":"sec-edgar","filing":"0001209191-23-038804","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123038804/doc4.xml","form_type":"4"}},{"id":1848182,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":89744,"kind":"person","name":"Dubovsky Filip","position":1,"cik":"0001977361","reported_name":"Dubovsky Filip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, R&D"}}],"security":"Common Stock","published_at":"2023-06-21T20:40:33.000Z","date":"2023-06-16","kind":"exercise","planned":false,"acquired":true,"shares":4155,"price":8.04,"value":33406.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were received by the reporting person in connection with vesting of restricted stock units (\"RSUs\")."}],"balance_after":47065,"source":{"system":"sec-edgar","filing":"0001209191-23-038804","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123038804/doc4.xml","form_type":"4"}}]}